Model of Reversible Cerebral Ischemia in a Monkey Model

American Journal of Neuroradiology

Volumn 24, Issue 9, 2003, Pages 1834-1836

  Jungreis, Charles A ^a,b   Nemoto, Edwin ^a   Boada, Fernando ^a   Horowitz, Michael B ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ARTERY OCCLUSION; ARTICLE; BLOOD FLOW; BRAIN ISCHEMIA; DISEASE MODEL; MAGNETIC RESONANCE ANGIOGRAPHY; MIDDLE CEREBRAL ARTERY; MONKEY; NONHUMAN; POSTERIOR CEREBRAL ARTERY; PRIMATE; REPERFUSION; STROKE;

ANIMALS; BRAIN ISCHEMIA; CEREBRAL ANGIOGRAPHY; DISEASE MODELS, ANIMAL; MACACA NEMESTRINA;

EID: 0142040654     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Hacke W, Kaste M, Fieschi C, et al for the ECASS study group. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017-1025
2. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587
3. Furlan A, Higashida R, Wechsler LR, et al for the PROACT Investigators. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study: a randomized controlled trial. JAMA 1999;282:2003-2011
4. Lewandowski CA, Frankel M, Tomsick TA, et al, and the EMS bridging trial investigators. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: emergency management of stroke (EMS) bridging trial. Stroke 1999;30:2598-2605
5. Lo EH, Matsumoto K, Pierce AR, Garrido L, Luttinger D. Pharmacologic reversal of acute changes in diffusion-weighted magnetic resonance imaging in focal cerebral ischemia. J Cereb Blood Flow Metab 1994;14:597-603
6. Marks MP, Tong DC, Beaulieu C, Albers GW, de Crespigny A, Moseley ME. Evaluation of early reperfusion and IV tPA therapy using diffusion- and perfusion-weighted MRI. Neurology 1999;52:1792-1798
7. Albers GW. Expanding the window for thrombolytic therapy in acute stroke: the potential role of acute MRI for patient selection. Stroke 1999;30:2230-2237
8. Firlik AD, Kaufmann AM, Wechsler LR, Firlik KS, Fukui MB, Yonas H. Quantitative cerebral blood flow determinations in acute ischemic stroke: relationship to computed tomography and angiography. Stroke 1997;28:2208-2213
9. Grotta J. Neuroprotection is unlikely to be effective in humans using current trial designs. Stroke 2002;33:306-307
10. Symon L, Pasztor E, Branston NM. The distribution and density of reduced cerebral blood flow following acute middle cerebral artery occlusion: an experimental study of the technique of hydrogen clearance in baboons. Stroke 1974;5:355-363
11. Yonas H, Wolfson SK, Dujovny M, Boehnke M, Cook E. Selective lenticulostriate occlusion in the primate: a highly focal cerebral ischemia model. Stroke 1981;12:567-572
12. Del Zoppo GJ, Copeland BR, et al. Experimental acute thrombotic stroke in baboons. Stroke 1986;17:1254-1265
13. Horowitz M, Kassam A, Nemoto E, Arimoto J, Jungreis C. An endovascular primate model for the production of a middle cerebral artery ischemic infarction. Intervent Neuroradiol 2001;7:223-228